• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Timing could matter to how responsive cancer cells are to treatment, study suggests

Bioengineer by Bioengineer
October 25, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CHAPEL HILL — DNA damage occurs routinely within your cells due to sun exposure, smoking and sometimes during the normal process of making new DNA. Fortunately, there are "checkpoints" in-place within cells to stop them from making more DNA and dividing before the damaged DNA is repaired. But in the case of cancer, cells may ignore these checkpoints, and go on to divide with damaged DNA.

In a new study published in Cell Systems, University of North Carolina Lineberger Comprehensive Cancer Center researchers report that the timing of when DNA damage occurs within these different checkpoints matters to a cell's fate. They believe their findings could be helpful in predicting the outcome of cancer treatment with radiation and chemotherapy, which cause severe damage to cancer cells' DNA, triggering them to stop division, and die.

"It's very important to look at the timing of cell damage because depending on when it occurs within a certain cell cycle, there can be a totally different outcome," said Sherry Chao, the paper's first author and a graduate research assistant in the UNC School of Medicine Department of Genetics. "Some stages of the cell cycle are very vulnerable to DNA damage."

For the study, the researchers used time-lapse microscopy to study cells as they moved through three cell cycle phases, tracking the fate of individual cells after they received DNA damage. They found that the cells' response to DNA damage during certain cell cycle phases was strong and completely halted the cell cycle. In other phases, however, cells were relatively less sensitive or showed delayed but steady progression.

They also discovered that within cell cycle phases, there are "commitment points" past which cells will move forward into the next cycle, regardless of damage. "If the cell cycle has already passed through the commitment point, then the cell will continue with cell cycle progression," Chao said. "But if we damage the cells before they pass through the commitment point, the checkpoint is still able to stop the cell cycle."

They used the data to build a mathematical model of how timing affects checkpoint behavior. The model suggests that the precise timing of DNA damage not only determines checkpoint behaviors, but also alters the cellular outcomes for damaged cells.

Researchers say the findings could inform new treatment strategies for administering common cancer therapeutics. Their findings suggest the possibility of synchronizing cancer cells in more susceptible cell cycle phases before treatment.

"Conceptually, it makes sense that if you could get all of the cells in the same cycle at the same time, you could damage them all with one shot," said UNC Lineberger's Jeremy Purvis, PhD, UNC Lineberger member and assistant professor in the UNC School of Medicine Department of Genetics. "The key will be finding ways to separate cancerous and healthy cells based on the timing and synchronization of their cell cycles."

Purvis added that their research adds the timing of treatment as an additional way of thinking about cancer research.

"If we can identify specific times when cancer cells will be more responsive to treatment, that's a fundamentally different approach than separating cells based on, say, a molecule you can detect on its surface."

###

In addition to Chao and Purvis, other authors includes Cere E. Poovey, Ashley A. Privette, Gavin D. Grant, Hui Yan Chao, and Jeanette G. Cook.

The study was supported by the National Institutes of Health, the University Cancer Research Fund, and the W.M. Keck Foundation.

Media Contact

Laura Oleniacz
[email protected]
919-445-4219

http://cancer.med.unc.edu/

https://unclineberger.org/news/timing-could-matter

Share13Tweet8Share2ShareShareShare2

Related Posts

β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

August 31, 2026
Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

August 31, 2026

KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

August 31, 2026

Virologist awarded $2 million NIH grant to investigate how virus-infected cells live and die

August 31, 2026
Please login to join discussion

POPULAR NEWS

  • β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

    29 shares
    Share 12 Tweet 7
  • Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

    29 shares
    Share 12 Tweet 7
  • KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

    29 shares
    Share 12 Tweet 7
  • Virologist awarded $2 million NIH grant to investigate how virus-infected cells live and die

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

β-Sitosterol from Ipomoea carnea Jacq. As a promising anti-inflammatory agent: Evidence from in silico modeling and in vitro validation

Design, fabrication and characterization of a wearable Fiber Bragg grating sensor for cardiorespiratory monitoring using finger plethysmography

KAIST opens the era of industrial-scale microbial foods, proposing growth strategies for the next-generation protein market

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.